Silvestris, N.; Simone, G.; Partipilo, G.; Scarpi, E.; Lorusso, V.; Brunetti, A.E.; Maiello, E.; Paradiso, A.; Mangia, A.
CES2, ABCG2, TS and Topo-I Primary and Synchronous Metastasis Expression and Clinical Outcome in Metastatic Colorectal Cancer Patients Treated with First-Line FOLFIRI Regimen. Int. J. Mol. Sci. 2014, 15, 15767-15777.
https://doi.org/10.3390/ijms150915767
AMA Style
Silvestris N, Simone G, Partipilo G, Scarpi E, Lorusso V, Brunetti AE, Maiello E, Paradiso A, Mangia A.
CES2, ABCG2, TS and Topo-I Primary and Synchronous Metastasis Expression and Clinical Outcome in Metastatic Colorectal Cancer Patients Treated with First-Line FOLFIRI Regimen. International Journal of Molecular Sciences. 2014; 15(9):15767-15777.
https://doi.org/10.3390/ijms150915767
Chicago/Turabian Style
Silvestris, Nicola, Giovanni Simone, Giulia Partipilo, Emanuela Scarpi, Vito Lorusso, Anna Elisabetta Brunetti, Evaristo Maiello, Angelo Paradiso, and Anita Mangia.
2014. "CES2, ABCG2, TS and Topo-I Primary and Synchronous Metastasis Expression and Clinical Outcome in Metastatic Colorectal Cancer Patients Treated with First-Line FOLFIRI Regimen" International Journal of Molecular Sciences 15, no. 9: 15767-15777.
https://doi.org/10.3390/ijms150915767
APA Style
Silvestris, N., Simone, G., Partipilo, G., Scarpi, E., Lorusso, V., Brunetti, A. E., Maiello, E., Paradiso, A., & Mangia, A.
(2014). CES2, ABCG2, TS and Topo-I Primary and Synchronous Metastasis Expression and Clinical Outcome in Metastatic Colorectal Cancer Patients Treated with First-Line FOLFIRI Regimen. International Journal of Molecular Sciences, 15(9), 15767-15777.
https://doi.org/10.3390/ijms150915767